Tailored Vancomycin Diversification and Synthetic Strategies. Brad Cox Michigan State University March 29, 2006
|
|
|
- Joan Lloyd
- 5 years ago
- Views:
Transcription
1 Tailored Vancomycin Diversification and Synthetic Strategies Brad Cox Michigan State University March 29, 2006
2 utline Bacterial and antibiotic awareness ecessity for novel antibiotics Antibiotic targets and modes of action Cell-wall biosynthesis Combinatorial natural product diversification Enzymatic diverisification Chemical modifications Synthetic glycopeptide mimics
3 Bacterial Facts Bacteria are everywhere from volcanoes to acid wells and icebergs inhabit most areas on your body can be pathogens Antibiotics subjection selection resistance Bioteach.ubc.ca
4 in 2005, 33 million pounds antibiotics consumed Subjection over-prescription Furuya, E.Y.; Lowy, F.D. at. Rev. Microbiol
5 in 2005, 33 million pounds antibiotics consumed Subjection over-prescription short generation times Selection evolution: mutations, gene transfer Furuya, E.Y.; Lowy, F.D. at. Rev. Microbiol
6 in 2005, 33 million pounds antibiotics consumed Subjection over-prescription short generation times Selection evolution: mutations, gene transfer 90% of S. aureus penicillin resistant Resistance call for new antibiotics Furuya, E.Y.; Lowy, F.D. at. Rev. Microbiol
7 Antibiotic Targets DA Replication and Repair fluoroquinones Protein Biosynthesis macrolides, tetracyclins, aminoglycosides, and oxazolidinones RA Transcription rifamycin and actinomycin Cell-wall Biosynthesis Glycopeptides β lactams penicillins, cephalosporins
8 Glycopeptide Properties eptapeptide scaffold Aromatic residues C 3 2 on-ribosomal amino acid production C 3 ighly oxidized Rigid, domed framework 2 Vancomycin
9 37% Increase in Prescriptions '04-'05 Isolation from Indian Soil Microbe Amycolatopsis orientalis $160 Million in 2005 Vancomycin "Last Resort" Antibiotic Taken Intraveniously Targets Gram + rganisms Padma, P..; Roa, A.B.; Yadav,J.S.; Reddy, G. Appl. Biochem. Biotech Smith, T.L. ew Eng. J Med
10 37% Increase in Prescriptions '04-'05 Isolation from Indian Soil Microbe Amycolatopsis orientalis $160 Million in 2005 Vancomycin "Last Resort" Antibiotic Taken Intraveniously Targets Gram + rganisms Padma, P..; Roa, A.B.; Yadav,J.S.; Reddy, G. Appl. Biochem. Biotech Smith, T.L. ew Eng. J Med
11 37% Increase in Prescriptions '04-'05 Isolation from Indian Soil Microbe Amycolatopsis orientalis $160 Million in 2005 Vancomycin "Last Resort" Antibiotic Taken Intraveniously Targets Gram + rganisms Padma, P..; Roa, A.B.; Yadav,J.S.; Reddy, G. Appl. Biochem. Biotech Smith, T.L. ew Eng. J Med
12 37% Increase in Prescriptions '04-'05 Isolation from Indian Soil Microbe Amycolatopsis orientalis $160 Million in 2005 Vancomycin "Last Resort" Antibiotic Taken Intraveniously Targets Gram + rganisms Padma, P..; Roa, A.B.; Yadav,J.S.; Reddy, G. Appl. Biochem. Biotech Smith, T.L. ew Eng. J Med
13 37% Increase in Prescriptions '04-'05 Isolation from Indian Soil Microbe Amycolatopsis orientalis $160 Million in 2005 Vancomycin "Last Resort" Antibiotic Taken Intraveniously Targets Gram + rganisms Padma, P..; Roa, A.B.; Yadav,J.S.; Reddy, G. Appl. Biochem. Biotech Smith, T.L. ew Eng. J Med
14 37% Increase in Prescriptions '04-'05 Isolation from Indian Soil Microbe Amycolatopsis orientalis $160 Million in 2005 Vancomycin "Last Resort" Antibiotic Taken Intraveniously Targets Gram + rganisms Padma, P..; Roa, A.B.; Yadav,J.S.; Reddy, G. Appl. Biochem. Biotech Smith, T.L. ew Eng. J Med
15 37% Increase in Prescriptions '04-'05 Isolation from Indian Soil Microbe Amycolatopsis orientalis $160 Million in 2005 Vancomycin "Last Resort" Antibiotic Taken Intraveniously Targets Gram + rganisms Padma, P..; Roa, A.B.; Yadav,J.S.; Reddy, G. Appl. Biochem. Biotech Smith, T.L. ew Eng. J Med
16 Vancomycin Total Syntheses Convergent syntheses Average steps: 95 Average yield: < 1% S Ar Cyclization S Ar Cyclization Macrolactamization 2 Peptide Coupling Suzuki Coupling Boger, D.L. J. Am. Chem. Soc. 1999, 121, Evans, D.A. Angew. Chem. Int. Ed. 1998, 37, icolaou, K.C. Chem. Eur. J. 1999, 5,
17 Vancomycin Total Synthesis 1 S Ar Cyclization 5 S Ar Cyclization C D E 3 Macrolactamization B 2 A 4 Peptide Coupling 2 Suzuki Coupling 2 Me F F ME M C Me 2 C Boc B() 2 TBS B Me Br D Boc Me 2 C C E 2 Me A Me Me Boger, D.L.; Miyazaki, S.; Kim, S..; Wu, J..; Jin, Q. J. Am. Chem. Soc. 1999, 121,
18 Cell-Wall Biosynthesis Ac Ac P _ L-Ala D-Glu P L-Lys Lipid D-Ala D-Ala Lipid II Precursor Glycotransferase _ Ac Ac L-Ala D-Glu L-Lys D-Ala D-Ala Ac Ac L-Ala D-Glu L-Lys 2 D-Ala D-Ala Transpeptidase D-Ala D-Ala L-Lys D-Glu L-Ala Ac Ac Schwarts, B.; Markwalder, J.A.; Wang, Yi. J. Am. Chem. Soc. 2001, 123,
19 Vancomycin Primary Mode of Action P _ Lipid II Precursor Lipid P _ Ac D-Ala D-Glu D-Ala L-Lys L-Ala Ac Cell Membrane L-Lys 2 Barna, J.C.J.; Williams, D.. Annu. Rev. Microbiol. 1984, 38, 339.
20 Glycopeptide Resistance 2 *Loss of 1 bond leads to a 1000-fold affinity decrease L-Lys Cell Membrane Bugg, T.D.; Dutka-Malen, S.; Arthur, M.; Courvalin, P. Biochemistry, 1991, 30, 2017.
21 eptapeptide Scaffold Engineering 2 Crowley, B.M.; Boger, D.L. J. Am. Chem. Soc. 2006, 128, 2885.
22 eptapeptide Scaffold Engineering fold binding Affinity increase over Vancomycin on VRSA Crowley, B.M.; Boger, D.L. J. Am. Chem. Soc. 2006, 128, 2885.
23 eptapeptide Scaffold Engineering 2 L-Lys Cell Membrane Crowley, B.M.; Boger, D.L. J. Am. Chem. Soc. 2006, 128, 2885.
24 Differential Glycopeptide Activities Against S. aureus In vitro activity (MIC 90 ) of glycopeptides Bacterial Species Status MIC 90 (mg/l) Vancomycin ritavancin Telavancin Teicoplanin Dalbavancin S. aureus MSSA MRSA VISA GRSA > MSSA methicillin sensitive S. aureus MRSA methicillin resistant S. aureus VISA vancomycin intermediate S. aureus GRSA glycopeptide resistant S. aureus. Van Bambeke, F. Curr. pin. Pharmacol. 2004, 4, 471.
25 Glycoside Effects C 3 R 1 Vancomycin R 1 =C 3 R 2 = R 2 Me C 3 R 1 Me R 3 Chlorobiphenyl Vancomycin Chlorobiphenyl Disaccharide R 1 =C 3 R 2 = R 3 = MIC (μg/ml) E. faecium E. faecalis Sensitive Resistant Sensitive Resistant vancomycin chlorobiphenyl vancomycin chlorobiphenyl disaccharide Ge, M.; Chen, Z.; nishi.r.; Kohler, J.; Kahne, D. Science, 1999, 284, 507.
26 Proposed Inhibition Models of ydrophobically Derivatized Vancomycin Membrane anchoring Dimerization Transglycosylase inhibition
27 Membrane Anchoring D-Ala D-Ala L-Lys D-Glu L-Ala 2 3 C C 3 Membrane Lipid Layer Lipid layer ydrophobic interactions Sharman, G.J.; Try, A.C.; Dancer, R.J.; Cho, Y.R.; Williams, D.. J. Am. Chem. Soc. 1997, 119,
28 Glycopeptide Vessicle Anchoring C C C 3 R 1 C 3 CE:Chloroeremomycin R 1 = BCE:Biphenyl R 1 = Sharman, G.J.; Try, A.C.; Dancer, R.J.; Cho, Y.R.; Williams, D.. J. Am. Chem. Soc. 1997, 119,
29 Glycopeptide Dimerization 2 3 C C 3 3 C C 3 2 Lipid II Lipid II Sharman, G.J.; Try, A.C.; Dancer, R.J.; Cho, Y.R.; Williams, D.. J. Am. Chem. Soc. 1997, 119,
30 Glycopeptide Dimerization 3 C 2 C 3 R 1 C 3 Dimerization Constant (M -1 ) Free Antibiotic Tripeptide Complex BCE(D) 1.6±0.2 x ±1.0 x 10 7 BCE() 2.0±1.0 x 10 5 CE(D) 1.8±0.6 x ±0.4 x 10 7 CE() 1.6±0.2 x 10 4 C 3 D 2 CE:Chloroeremomycin R 1 = BCE:Biphenyl R 1 = Sharman, G.J.; Try, A.C.; Dancer, R.J.; Cho, Y.R.; Williams, D.. J. Am. Chem. Soc. 1997, 119,
31 Transglycosylase Inhibition Chlorobiphenyl- R 2 = C 3 C 3 2 R 2 Vancomycin R 1 = R 1 R 2 = Damaged Vancomycin R 1 = R 2 = C Ac 2 R 3 = Ac C 2 C 2 R 3 P Moenomycin Delipidated Moenomycin R 3 = Chen, L.; Walker, D.; Sun, B.; Kahne, D. Proc. atl. Acad. Sci. 2003, 100, 5658.
32 Transglycosylase Inhibition C Ac 2 C 2 P Ac Moenomycin C 2 R 3 R 3 = Delipidated Moenomycin R 3 = Compound IC 50 (μg/ml) vancomycin 0.38 damaged vancomycin 144 chlorobiphenyl vancomycin 1.5 damaged chlorobiphenyl vancomycin 3.88 moenomycin damaged moenomycin 2.23 Chen, L.; Walker, D.; Sun, B.; Kahne, D., Proc. atl. Acad. Sci. 2003, 100, 5658.
33 Transglycosylase Inhibition C 3 C 3 R 2 R 1 2 Vancomycin R 1 = R 2 = Chlorobiphenyl- R 2 = Damaged Vancomycin R 1 = R 2 = Compound IC 50 (μg/ml) vancomycin 0.38 damaged vancomycin 144 chlorobiphenyl vancomycin 1.5 damaged chlorobiphenyl vancomycin 3.88 moenomycin damaged moenomycin 2.23 Chen, L.; Walker, D.; Sun, B.; Kahne, D., Proc. atl. Acad. Sci. 2003, 100, 5658.
34 Efficacy Comparision of ydrophobic Chain Length MIC (μg/ml) Compound n Methicillin Resistant S. aureus n n C 3 C 3 n vancomycin aglycon Ge, M.; Chen, Z.; nishi.r.; Kohler, J.; Kahne, D. Science, 1999, 284, 507. Mu, Y.; odwell, M.; Pace, J.L.; Shaw, J.P. Bioorg. Med. Chem. Lett. 2004, 14, 735. Kubo, I.; Fujita K.; ihei, K.; Masuoka,. Bioorg. Med. Chem. 2003, 11, 573. Klink, J.W.; Larsen, L.; Perry,.B.; Weavers, R.T.; Cook, G.M.; Bioorg. Med. Chem. 2005, 13, 6651.
35 Enzymatic Diversification C C C 3 C 3 2
36 Enzymatic Glycosylation Vancomycin Aglycon P - P - R GtfE TDP 2 Vancomycin Aglycon GtfD TDPsugar TDP-4-epi- Vancosamine UDP Gtf - Glycotransferase Vancomycin Aglycon Losey,.C.; Jiang, J.; Biggins, J.B.; Kahne, D.; Thorson, J.S.; Walsh, C.T. Chem. Biol. 2002, 9, 1305.
37 Enzymatic Glycosylation GtfA TDP epi-vancosamine 3 C 2 C 3 Chloroorienticin B GtfD TDP vancosamine Gtf - Glycotranferase GtfC TDP epi-vancosamine Vancomycin C C C 3 2 C 3 Chloroeremomycin berthur, M.; Leimkuhler, C.; Kruger, R.G.; Lu, W.; Kahne, D.; Walsh, C.T. J. Am. Chem. Soc. 2005, 127,
38 Chemical Modification 3 C 3 2 C 3 2 2
39 Glycorandomization 3 R 1 CuI, 70 C, 12 h 35-87% R 1 Fu, X.; Albermann, C.; Jiang, J.; Zhang, C.; Thorson, J. ature Biotech. 2003, 21, Fu, X.; Albermann, C.; Zhang, C.; Thorson, J. rg. Lett. 2005, 7, 1513.
40 Derivatized Sugar Effect on Vancomycin Efficacy Ph C S MIC (µg/ml) Compound S. aureus E. faecalis E. faecium Van >24 >24 4 > Fu, X.; Albermann, C.; Zhang, C.; Thorson, J. rg. Lett. 2005, 7, 1513.
41 Derivatized Sugar Effect on Vancomycin Efficacy Ph C S MIC (µg/ml) Compound S. aureus E. faecalis E. faecium Van >24 >24 4 > o increased efficacy Fu, X.; Albermann, C.; Zhang, C.; Thorson, J. rg. Lett. 2005, 7, 1513.
42 Solid Phase Vancosamine and -terminus Derivitization C 3 R 1 C 3 2 R 2 MIC (μg/ml) Vancosamine R 1 -terminus R 2 E. faecalis E. faecalis Resistant S. aureus F 2.5 > > >10 5 Vancomycin C > Demethylvancomycin 2.5 >10 <0.6 Fmoc C > Yao,..; Liu, G.; e, W.Y. Bioorg. Med. Chem. Lett. 2005, 15, 2325.
43 Enzymatic Glucosamine Acylation 2 aatf or tatf (n) CoA n=2-16 (n) Atf - acetyltransferase Kruger, R.G.; Lu, W.; berthur, M.; Kahne, D.; Walsh, C.T. Chem. Biol. 2005, 12, 131.
44 Lipoglycopeptide Efficacy Comparison C 3 C 3 n X m 2 MIC 50 (μg/ml) Entry X n m MSSA MRSA GRSA 1 S-S S-S S-S C Vancomycin >256 Mu, Y.; odwell, M.; Pace, J.L.; Shaw, J.P. Bioorg. Med. Chem. Lett. 2004, 14, 735.
45 Tissue Distribution C 3 X C 3 2 % dose X in liver in kidney in urine S-S C * 50 mg/kg dose Mu, Y.; odwell, M.; Pace, J.L.; Shaw, J.P. Bioorg. Med. Chem. Lett. 2004, 14, 735.
46 Attempted RCM-Based Vancomycin Mimic Synthesis 2 Me Boc Boc Brink,.T.; Rijkers, D.T.S.; Kemmink, J.; ilbers,.w.; Liskamp, R.M.J. rg. Biomol. Chem. 2004, 2, 2658.
47 Attempted RCM-Based Vancomycin Mimic Synthesis Mes Mes Ru Ph PCy 3 Boc overall 18.2 % Boc Brink,.T.; Rijkers, D.T.S.; Kemmink, J.; ilbers,.w.; Liskamp, R.M.J. rg. Biomol. Chem. 2004, 2, 2658.
48 Partial Tripeptide Vancomycin Mimic R 2 R 3 I Sonagashira Cyclization 6-23% R 4 R 1 Boc R 3 R 2 R 5 R 2 Boc R 4 Boc R 1 R 3 R 4 Boc t-bu Macrolactamization 54-61% R 1 Brink,.T.; Rijkers, D.T.S.; Liskamp, M.J. J. rg. Chem. 2006, 71, 1817.
49 Lactamization of Partial Vancomycin Mimic ATU _ + PF 6 I + Boc Cbz t-bu + _ + 80% 10% Pd(PPh 3 ) 4 10% CuI Et 2 TF Cbz Boc t-bu 1)TFA/C 2 2 1:1 2)ATU/At/DIPEA DMF 0.5mM 54% Cbz Brink,.T.; Rijkers, D.T.S.; Liskamp, M.J. J. rg. Chem. 2006, 71, 1817.
50 Future Synthetic Strategy I Me Me Me R 1 Boc R 5 Me R 1 R 1 Boc R 5 Brink,.T.; Rijkers, D.T.S.; Liskamp, M.J. J. rg. Chem. 2006, 71, 1817.
51 Conclusion Abuse of antibiotics ecessity for cycles of new antibiotics Synergistic enzymatic and chemical derivitization of the glycopeptide scaffold Enzymatic diversification Future synthetic efforts for further and more robust diversification Chemical Modification
52 Acknowledgements John Frost Karen Frost Group Members Vu Bui Steve Cheley Jiantao Guo Justas Jancauskas Man Kit Lau ingqing Ran eather Stueben Dongming Xie Jinsong Yang Jennifer Froelich Emma s Bakery in kemos
A Novel Lantibiotic Acting on Bacterial Cell Wall Synthesis Produced by the Uncommon FLAVIA MARINELLI. DBSM, University of Insubria, Varese Italy
A Novel Lantibiotic Acting on Bacterial Cell Wall Synthesis Produced by the Uncommon Actinomycete Planomonospora sp. FLAVIA MARINELLI DBSM, University of Insubria, Varese Italy Vicuron Pharmaceuticals,
GLYCOPEPTIDES : how can a structural modification bring to a new life an old family of antibiotics?
GLYCPEPTIDES : how can a structural modification bring to a new life an old family of antibiotics? F. Van Bambeke Pharmacologie cellulaire et moléculaire Université catholique de Louvain Brussels - Belgium
Spectrum of vancomycin and susceptibility testing
Spectrum of vancomycin and susceptibility testing Olivier Denis Service de Microbiologie Laboratoire de bactériologie Service de Microbiologie Hôpital Erasme Glycopeptides Vancomycin 1958 < Amycolatopsis
The Activity of Glycopeptide Antibiotics Against Resistant Bacteria Correlates with their Ability to
AAC Accepts, published online ahead of print on August 1 Antimicrob. Agents Chemother. doi:1.118/aac.38-1 Copyright 1, American Society for Microbiology. All Rights Reserved. 1 3 The Activity of Glycopeptide
New Insights into Peptidoglycan Biosynthesis. Louis B. Rice Warren Alpert Medical School of Brown University Providence, RI
New Insights into Peptidoglycan Biosynthesis Louis B. Rice Warren Alpert Medical School of Brown University Providence, RI Outline of Presentation Review role of penicillin-binding proteins in cell wall
CLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel
CLINICAL USE OF GLYCOPEPTIDES Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel Glycopeptides Natural Vancomycin introduced in 1958 Teicoplanin introduced in Europe
Final Report Bande Omprakash. Synthesis of Lipid I and Lipid II monophosphate analogues of Moenomycin for inhibition of transglycosylases.
Final Report 2011-2012 Bande mprakash Synthesis of Lipid I and Lipid II monophosphate analogues of Moenomycin for inhibition of transglycosylases. Moenomycin A is a natural product which interrupts cell
ESCMID Online Lecture Library. by author
Hospital Universitario Virgen Macarena, Seville New drugs against MRSA and VRE L. Eduardo López Cortés Seville, 8th July Tedizolid Oxazolidinone Ceftaroline // Ceftobiprole 5 th gen cephalosporin Overview
Author's personal copy
Drugs (2015) 75:2073 2095 DI 10.1007/s40265-015-0505-8 REVIEW ARTICLE Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review Françoise Van Bambeke 1 Published online: 24
Cases in employees. Cases. Day of onset (July)
Cases in employees 70 60 50 Cases 40 30 20 10 0 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 Day of onset (July) 70 60 50 40 Cases 30 Cases in employees and visitors Employees Visitors 20 10 0 0 2 4 6 8
Activity of antibiotics against intracellular S. aureus
Activity of antibiotics against intracellular S. aureus F. Van Bambeke Unité de Pharmacologie cellulaire et moléculaire Université catholique de Louvain Brussels, Belgium Disclosures Grants-in-aid from
Development of Small Molecule Inhibitors of the Lethal Factor in Anthrax. Brian Englund Michigan State University September 13, 2006
Development of mall Molecule Inhibitors of the Lethal Factor in Anthrax Brian Englund Michigan tate University eptember 13, 2006 Introduction Proteolysis Mechanism Anthrax Inhibitors Panchal and Bavari
Resistance to new anti-grampositive. Roland Leclercq, Microbiology, CHU Cote de Nacre, Caen, France
Resistance to new anti-grampositive agents Roland Leclercq, Microbiology, CHU Cote de Nacre, Caen, France Recently available antimicrobials against MDR Gram-positive infections Cyclic lipopeptide: daptomycin
Shirin Abadi, B.Sc.(Pharm.), ACPR, Pharm.D. Clinical Pharmacy Specialist & Pharmacy Education Coordinator, BC Cancer Agency Clinical Associate
Shirin Abadi, B.Sc.(Pharm.), ACPR, Pharm.D. Clinical Pharmacy Specialist & Pharmacy Education Coordinator, BC Cancer Agency Clinical Associate Professor of Pharmacy & Associate Member of Medicine, UBC
Other β-lactam. A. Carbapenems:
A. Carbapenems: Other β-lactam Carbapenems are synthetic β-lactam antibiotics Differ in structure from the penicillins in that the sulfur atom of the thiazolidine ring. Imipenem, meropenem, doripenem,
Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides
Clin Pharmacokinet (2018) 57:797 816 https://doi.org/10.1007/s40262-017-0623-4 REVIEW ARTICLE Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides Valentin
Microbiology - Problem Drill 16: Antibiotics. Question No. 1 of 10. Question. Feedback. Question
Microbiology - Problem Drill 16: Antibiotics No. 1 of 10 1. An effective chemotherapeutic drug should have. (A) Low therapeutic index (B) More toxicity (C) Selective toxicity (D) Mutation inducing properties
Module Contact: Dr Paul McDermott, PHA Copyright of the University of East Anglia Version 1
UIVERSITY F EAST AGLIA School of Pharmacy Main Series UG Examination 2012-13 LIFE SCIECES CHEMISTRY PHA-1ECY Time allowed: 2 hours You must answer FUR (4) of the SIX (6) questions. Use a SEPARATE answer
Antibiotics.. Tetracyclines. Aminoglycoside. Macrolides. Chloramphenicol
Antibiotics. Tetracyclines. Aminoglycoside. Macrolides. Chloramphenicol Antibiotics as disturber with the biosynthesis of protein These antibiotics all target the bacterial ribosome and interfere in the
Antibiotics for Research
Antibiotics for Research Natural antibiotics have existed for centuries prior to scientists identifying and isolating active moieties responsible for antibacterial activity. Today antibiotics are widely
COO - l. H 3 N C a H l R 1
COO - l + H 3 N C a H l R 1 Amino acids There are 20 standard amino acids. All proteins are built from the same amino acids. The most important criteria for classification is affinity to water: hydrophilic
BIOCHEMISTRY LECTURES BY RASAQ, N.O
BIOCHEMISTRY LECTURES BY RASAQ, N.O LECTURE CONTENT INTRODUCTION POLYSACCHARIDES STRUCTURAL POLYSACCHARIDES: CELLULOSE AND CHITIN BACTERIA CELL WALLS PEPTIDOGLYCAN PENICILLIN AND β-lactam ANTIBIOTICS AND
Table removed due to copyright reasons.
atural Product Biosynthesis Relevance of natural products in the pharmaceutical industry (see Table 2 in Butler J. at. Prod. 2004, 67, 2141-2153.)) Table removed due to copyright reasons. 2 * a phosphopantetheinyl
Nucleophilic Addition to a p-benzyne Derived from an Enediyne: A New Mechanism for Halide Incorporation into Biomolecules
Nucleophilic Addition to a p-benzyne Derived from an Enediyne: A New Mechanism for Halide Incorporation into Biomolecules Perrin, C. L.; Rodgers, B. L.; O Connor, J. M. J. Am. Chem. Soc. 2007, ASAP John
Vancomycin is a member of the glycopeptide class of antibiotics. Vancomycin resistance
Chapter # Vancomycin Resistance VanS/VanR Two-Component omponent Systems Hee Jeon Hong, Matthew I. Hutchings and Mark J. Buttner* Abstract Vancomycin is a member of the glycopeptide class of antibiotics.
Medicinal Chemistry of Modern Antibiotics
Chemistry 259 Medicinal Chemistry of Modern Antibiotics Spring 2012 Lecture 6: Antibiotics Classes & Targets Part I: Drugs Targeting Bacterial Cell Wall & Membrane Thomas Hermann Department of Chemistry
This article was published in an Elsevier journal. The attached copy is furnished to the author for non-commercial research and education use, including for instruction at the author s institution, sharing
life-threatening infections
Vancomycin Vancomycin has become increasingly important in the treatment of life-threatening infections. MRSA infections. Methicillin-resistant Staphylococcus epidermidis (MRSE) infections Enterococcal
Synthesis of Tamiflu and its Phosphonate Congeners Possessing Potent Anti-Influenza Activity
Synthesis of Tamiflu and its Phosphonate Congeners Possessing Potent Anti-Influenza Activity Shie, J. et al. J. Am. Chem. Soc. 2007, 129, 11892-11893. Intramolecular eck eactions of Unactivated Alkyl alides
Medicinal Chemistry of Modern Antibiotics
Chemistry 259 Medicinal Chemistry of Modern Antibiotics Spring 2008 Lecture 6: Antibiotics Classes & Targets Part I: Drugs Targeting Bacterial Cell Wall & Membrane Thomas Hermann Department of Chemistry
Moderate-Level Resistance to Glycopeptide LY Mediated by Genes of the vana and vanb Clusters in Enterococci
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1999, p. 1875 1880 Vol. 43, No. 8 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Moderate-Level Resistance to
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 18 October 2006
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 18 October 2006 CUBICIN 350 mg (daptomycin), powder for perfusion solution Box of 1 bottle (CIP code: 567 219-3) CUBICIN
From the Structure and Function of the Ribosome to new Antibiotics
From the Structure and Function of the Ribosome to new Antibiotics Crick s central dogma of molecular biology: DNA makes DNA makes RNA makes protein Jim Watson, 1964 J.A. Lake, 1976 (J.M.B. 105, 131)
Adenium Biotech. Management: - Peter Nordkild, MD, CEO, ex Novo Nordisk, Ferring, Egalet - Søren Neve, PhD, project director, ex Lundbeck, Novozymes
Adenium Biotech Management: - Peter Nordkild, MD, CEO, ex Novo Nordisk, Ferring, Egalet - Søren Neve, PhD, project director, ex Lundbeck, Novozymes Board of Directors: - Stephan Christgau, PhD, chairman,
Infectious Disease in the Critically Ill Patient
Infectious Disease in the Critically Ill Patient Heather L. Evans, MD MS FACS Director of Surgical Infectious Disease Harborview Medical Center Asst. Professor UW Department of Surgery New Antibiotics:
Antibiotics and Ribosomes as Drug Targets
Antibiotics and Ribosomes as Drug Targets www.biochemj.org/bj/330/0581/bj3300581.htm Professor Vassie Ware Bioscience in the 21 st Century November 5, 2012 PERSPECTIVE Widespread use of antibiotics after
Finding the Sweet Spot- Mechanism Guided Design of Glycosidase Inhibitors. Jahnabi Roy CHEM 575 Seminar 11/01/12
Finding the Sweet Spot- Mechanism Guided Design of Glycosidase Inhibitors Jahnabi Roy CHEM 575 Seminar 11/01/12 Glycans and Glycosyl Hydrolases http://cellbiology.med.unsw.edu.au/units/science/lecture0803.htm
prophylaxis for endocarditis in patients at high risk prophylaxis for major surgical procedures
1 Glycopeptides appropriate uses serious infections due to beta-lactam- resistant gram-positive microorganisms infections due to gram-positive microorganisms in patients with serious allergy to beta-lactam
Significance and Functions of Carbohydrates. Bacterial Cell Walls
Biochemistry 462a - Carbohydrate Function Reading - Chapter 9 Practice problems - Chapter 9: 2, 4a, 4b, 6, 9, 10, 13, 14, 15, 16a, 17; Carbohydrate extra problems Significance and Functions of Carbohydrates
VISA infections. Jean Ralph Zahar Infection Control Unit GH Paris Seine Saint Denis
VISA infections Jean Ralph Zahar Infection Control Unit GH Paris Seine Saint Denis jeanralph.zahar@aphp.fr H VISA and VISA infections Jean Ralph Zahar Infection Control Unit GH Paris Seine Saint Denis
Development of C sporins. Beta-lactam antibiotics - Cephalosporins. Second generation C sporins. Targets - PBP s
Beta-lactam antibiotics - Cephalosporins Development of C sporins Targets - PBP s Activity - Cidal - growing organisms (like the penicillins) Principles of action - Affinity for PBP s Permeability properties
Margaret A. Daugherty. Announcements! Fall Michaelis Menton Kinetics and Inhibition. Lecture 14: Enzymes & Kinetics III
Lecture 14: Enzymes & Kinetics III Michaelis Menton Kinetics and Inhibition Margaret A. Daugherty Fall 2004 Announcements! Monday 10/11 lecture: starts at 10:15; Taught by Dr. Stephen Everse o ffice our/review
Serious MRSA infection: anything new?
Serious MRSA infection: anything new? Professor Mark H. Wilcox Leeds Teaching Hospitals & University of Leeds, UK Public Health England & NHS Improvement Potential Conflicts of Interest I have received:
A Platform for the Discovery of New Macrolide Antibiotics
A Platform for the Discovery of New Macrolide Antibiotics Ian B. Seiple, Ziyang Zhang, Pavol Jakubec, Audrey Langlois-Mercier, Peter M. Wright, Daniel T. Hog, Kazuo Yabu, Senkara Rao Allu, Takehiro Fukuzaki,
Medicinal Chemistry 410 Exam #1 February 20, 2009 Name: Med. Chem. #
Medicinal Chemistry 410 Exam #1 February 20, 2009 ame: Med. Chem. # 1 Part. (75 Points) There are 50 multiple choice questions worth 1.5 points each (75 Points). Please use the cantron heet provided. f
Supplementary Information
Supplementary Information Assembly and Clustering of Natural Antibiotics Guides Target Identification Chad W. Johnston 1,2, Michael A. Skinnider 1,2, Chris A. Dejong 1,2, Philip N. Rees 1,2, Gregory M.
Chapter 4. Erythronolide B and the Erythromycins
124 Chapter 4 Erythronolide B and the Erythromycins Isolation and tructure Isolated in 1952 from the soil bacteria actinomycetes, 1 the erythromycins are a distinguished family of natural products by virtue
Intracellular infection and activity of antibiotics: concepts and examples with Staphylococcus aureus and Listeria monocytogenes
Intracellular infection and activity of antibiotics: concepts and examples with Staphylococcus aureus and Listeria monocytogenes Paul M. Tulkens, MD, PhD Cellular and Molecular Pharmacology Unit Catholic
EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING
EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING Commentary provided by: Julie Hall, MHS, MT (ASCP) Assistant Dean, College of Health Professions Assistant Professor, Medical Laboratory Science Grand Valley
Chapter 10. 이화작용 : 에너지방출과보존 (Catabolism: Energy Release and Conservation)
Chapter 10 이화작용 : 에너지방출과보존 (Catabolism: Energy Release and Conservation) 1 Fueling Processes Respiration 1 Most respiration involves use of an electron transport chain As electrons pass through the electron
Genetic information flows from mrna to protein through the process of translation
Genetic information flows from mrn to protein through the process of translation TYPES OF RN (RIBONUCLEIC CID) RN s job - protein synthesis (assembly of amino acids into proteins) Three main types: 1.
Synthesis of novel Small Molecule (Nonpeptidic) Inhibitors (SMNPIs) of the BoNT/A LC metalloprotease
ynthesis of novel mall Molecule (onpeptidic) Inhibitors (MPIs) of the BoT/A LC metalloprotease Igor psenica Ph.D. Wipf Group Research eminar eptember 24 th, 2011 Igor psenica @ Wipf Group Page 1 of 18
Total Synthesis of Platencin
Total Synthesis of Platencin 2 C N Platencin K. C. Nicolaou,* G. Scott Tria, David J. Edmonds Angew. Chem. Int. Ed. 2008, 47, 1780-1783. Shuli Mao Current Literature Presentation 02-16-2008 Shuli Mao @
Correlation between the Treatment Result and Causative Bacteria in Amputation of Diabetic Foot
Correlation between the Treatment Result and Causative Bacteria in Amputation of Diabetic Foot Department of Orthopaedic Surgery, College of Medicine, Dong-A university, Busan, Korea Myoung Jin Lee M.D.,
NEW ANTI-INFECTIVE AGENTS IN 2003 : SPECTRUM AND INDICATIONS. 20th Symposium (spring 2003) Thursday May 22nd 2003
NEW ANTI-INFECTIVE AGENTS IN 2003 : SPECTRUM AND INDICATIONS 20th Symposium (spring 2003) Thursday May 22nd 2003 The slides presented at this meeting are available on this site as "Web slide shows" and
Resistance to commonly used antibiotics is a major clinical
The molecular basis of vancomycin resistance in clinically relevant Enterococci: Crystal structure of D-alanyl-D-lactate ligase (VanA) David I. Roper*, Trevor Huyton, Alexei Vagin, and Guy Dodson York
Objectives: Prof.Dr. H.D.El-Yassin
Protein Synthesis and drugs that inhibit protein synthesis Objectives: 1. To understand the steps involved in the translation process that leads to protein synthesis 2. To understand and know about all
Graphene Quantum Dots-Band-Aids Used for Wound Disinfection
Supporting information Graphene Quantum Dots-Band-Aids Used for Wound Disinfection Hanjun Sun, Nan Gao, Kai Dong, Jinsong Ren, and Xiaogang Qu* Laboratory of Chemical Biology, Division of Biological Inorganic
MINIREVIEW. of the N-methylleucine of vancomycin. Both these antibiotics are less active than vancomycin.
ANTIMICROBIAL AGENTS AND CEMOTERAPY, Apr. 1991, p. 605-609 0066-4804/91/040605-05$02.00/0 Copyright 1991, American Society for Microbiology Vol. 35, No. 4 MINIREVIEW Antibacterial Activities and Modes
The Chemistry of Nine-Membered. Enediyne Natural Products
The Chemistry of ine-mbered Enediyne atural Products Zhang Wang MacMillan Group eting April 17, 2013 atural Products Sharing a Unique Structure C cyanosporaside A [] R 2 R sporolide A C [] [] R 1 R 1 =,
Medical Interventions- Unit 1 Study Guide (Due Dec. 16 th!)
Medical Interventions- Unit 1 Study Guide (Due Dec. 16 th!) Name: Lesson 1.1 1. Define medical intervention. What are 3 medical interventions that Sue Smith would have encountered during her infection
Catalytic decarboxylative alkylation of β-keto acids with sulfonamides via the cleavage of carbon nitrogen and carbon carbon bonds
Catalytic decarboxylative alkylation of β-keto acids with sulfonamides via the cleavage of carbon nitrogen and carbon carbon bonds Cui-Feng Yang, Jian-Yong Wang and Shi-Kai Tian* Joint Laboratory of Green
Medical Interventions- Unit 1 Study Guide (Due Dec. 15 th!)
Medical Interventions- Unit 1 Study Guide (Due Dec. 15 th!) Name: Lesson 1.1 1. Define medical intervention. What are 3 medical interventions that Sue Smith would have encountered during her infection
Classification of amino acids: -
Page 1 of 8 P roteinogenic amino acids, also known as standard, normal or primary amino acids are 20 amino acids that are incorporated in proteins and that are coded in the standard genetic code (subunit
ICU Volume 11 - Issue 3 - Autumn Series
ICU Volume 11 - Issue 3 - Autumn 2011 - Series Impact of Pharmacokinetics of Antibiotics in ICU Clinical Practice Introduction The efficacy of a drug is mainly dependent on its ability to achieve an effective
A. B. C. D. E. F. G. H. I. J. K. Ser/Thr. Ser/Thr. Ser/Thr. Ser/Thr. Ser/Thr. Asn. Asn. Asn. Asn. Asn. Asn
A. B. C. D. E. F. "3 "3!4!3 Ser/Thr "3!4!3!4 Asn Asn Ser/Thr Asn!3!6 Ser/Thr G. H. I. J. K.!3 Ser/Thr Ser/Thr 4 4 2 2 6 3 6 Asn Asn Asn Glycosidases and Glycosyltransferases Introduction to Inverting/Retaining
Chem 135: First Midterm
Chem 135: First Midterm September 28 th, 2007 Please provide all answers in the space provided. Extra paper is available if needed. You may not use calculators for this exam, but you are free to use (previously
The Curious Intersection of HIV and Staphylococcus aureus with a Focus on MRSA
The Curious Intersection of HIV and Staphylococcus aureus with a Focus on MRSA Franklin D. Lowy, MD Columbia University College of Physicians & Surgeons New York, NY Topics to Be Covered Background Some
Study of On-Resin Convergent Synthesis of N-Linked. Glycopeptides Containing a Large High Mannose N- Linked Oligosaccharide
Supporting Information Study of On-Resin Convergent Synthesis of N-Linked Glycopeptides Containing a Large High Mannose N- Linked Oligosaccharide Rui Chen and Thomas J. Tolbert* Department of Chemistry,
Vancomycin. A bactericidal drug which acts by inhibiting cell wall synthesis. Active only against gram-positive bacteria, particularly staphylococci.
Vancomycin A bactericidal drug which acts by inhibiting cell wall synthesis. Active only against gram-positive bacteria, particularly staphylococci. Used IV in treating endocarditis caused by methicillin-resistant
USA. Supplemental Information
Cloning and sequencing of the kedarcidin biosynthetic gene cluster from Streptoalloteichus sp. ATCC 53650 revealing new insights into biosynthesis of the enediyne family of antitumor antibiotics Jeremy
Pharmacodynamic indices in targeting therapy of critical infections
Pharmacodynamic indices in targeting therapy of critical infections P.M. Tulkens Cellular and Molecular Pharmacology, Catholic University of Louvain, Brussels, Belgium & International Society of Anti-infective
(telavancin) Healthcare Professional s Guide. Version 2, 4 November 2014
VIBATIV (telavancin) Healthcare Professional s Guide Version 2, 4 November 2014 1 Table of Contents Introduction... 3 About Vibativ / Therapeutic indications... 3 Antimicrobial spectrum of activity for
2016:26: % [1] Frederick Foley 9,600 25% [2,3] DOI: /ICJ
![2016:26: % [1] Frederick Foley 9,600 25% [2,3] DOI: /ICJ](/thumbs/93/114528525.jpg "2016:26: % [1] Frederick Foley 9,600 25% [2,3] DOI: /ICJ")
203 1,3 1,2,3 1 2 3 2016:26:203-209 Frederick Foley 4 95% [1] 9,600 25% [2,3] 105 6 15 105 8 31 201 02-28757462 DOI: 10.6526/ICJ.2016.503 105 10 204 [4-6] ( ) (extraluminal infection) (endogenous) 70%
TECHNICAL BULLETIN. R 2 GlcNAcβ1 4GlcNAcβ1 Asn
GlycoProfile II Enzymatic In-Solution N-Deglycosylation Kit Product Code PP0201 Storage Temperature 2 8 C TECHNICAL BULLETIN Product Description Glycosylation is one of the most common posttranslational
PROTEIN TRAFFICKING. Dr. SARRAY Sameh, Ph.D
PROTEIN TRAFFICKING Dr. SARRAY Sameh, Ph.D Overview Proteins are synthesized either on free ribosomes or on ribosomes bound to endoplasmic reticulum (RER). The synthesis of nuclear, mitochondrial and peroxisomal
1. Denaturation changes which of the following protein structure(s)?
Chem 11 Fall 2008 Examination #5 ASWER KEY MULTIPLE CICE (20 pts. total; 2 pts. each) 1. Denaturation changes which of the following protein structure(s)? a. primary b. secondary c. tertiary d. both b
Treatment of prosthetic joint infection. Alex Soriano Department of Infectious Diseases Hospital Clínic of Barcelona
Treatment of prosthetic joint infection Alex Soriano Department of Infectious Diseases Hospital Clínic of Barcelona Barret L, et al. The clinical presentation of prosthetic joint infection. J Antimicrob
Methicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods
Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance Report 2008 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services
In Vitro Susceptibility of Staphylococci and Enterococci to Vancomycin and Teicoplanin
In Vitro Susceptibility of Staphylococci and Enterococci to Vancomycin and Teicoplanin 19 A. Guzek, K. Korzeniewski, Aneta Nitsch-Osuch, Z. Rybicki, and E. Prokop Abstract Hospital-acquired infections
Received 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005
Journal of Antimicrobial Chemotherapy (2005) 56, 1047 1052 doi:10.1093/jac/dki362 Advance Access publication 20 October 2005 Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity,
Metal Species for Amide Hydrolysis. Literature Seminar, Kiyomichi SHINODA (M1)
Metal Species for Amide ydrolysis Literature Seminar, 20130511 Kiyomichi SIDA (M1) Table of Contents 1 Introduction 2 Residue- or Sequence-Selective ydrolysis of Amides 3 Protein-Selective ydrolysis of
Glycosidic bond cleavage
Glycosidases and Glycosyltransferases Introduction to Inverting/Retaining Mechanisms Inhibitor design Chemical Reaction Proposed catalytic mechanisms Multiple slides courtesy of Harry Gilbert with Wells
The use of Chiral Ketones /Aldehydes in the Asymmetric Epoxidation of Olefins. Somnath Bhattacharjee Michigan State University 12th January, 2005
The use of Chiral Ketones /Aldehydes in the Asymmetric Epoxidation of lefins Somnath Bhattacharjee Michigan State University 12th January, 2005 Introduction Sharpless Asymmetric Epoxidation 3 C C 2 (-)-diethyl
Home Page Table of Contents Reviews Editorial Board Contact Us
of 1 http://www.antimicrobe.org/ 31/01/2010 09:32 AM Home Page Table of Contents Reviews Editorial Board Contact Us Staphylococcus aureus Review of C. difficile Therapy Chagas Disease What's New Review
Questions on Disease and Immunity
Name: Questions on Disease and Immunity Directions: The following questions are taken from previous IB Final Papers on Topic 6.3 (Defence against infectious disease). Answer all questions. This will serve
Objective: You will be able to explain how the subcomponents of
Objective: You will be able to explain how the subcomponents of nucleic acids determine the properties of that polymer. Do Now: Read the first two paragraphs from enduring understanding 4.A Essential knowledge:
Antibiotic Classification Antibiotic Classification and Modes of Action
and Modes of Action Part # 60-00415-0 1 biomérieux, the blue logo and VITEK are used, pending and/or registered trademarks belonging to biomérieux SA or one of its subsidiaries. CLSI is a registered trademark
With approval of the Common Belgian Medical Ethical platform - visa no. 13/V1/5871/054190
Approaches to Current and Future Treatment ptions in Gram-positive Infections Paul M. Tulkens, MD, PhD Louvain Drug Research Institute Université catholique de Louvain Brussels, Belgium With approval of
INFLUENZA VIRUS. Influenza virus
IFLUEZA VIRUS Adapté en partie des exposés de la Chaire Franqui 2003 "Antiviral drugs and Discoveries in Medicine" Prof. E. De Clercq, KU-Leuven http://www.md.ucl.ac.be/chaire-francqui/ Influenza virus
Biochemistry of Peptide Antibiotics
Biochemistry of Peptide Antibiotics Recent Advances in the Biotechnology of js-lactams and Microbial Bioactive Peptides Editors Horst Kleinkauf Hans von Dohren W DE G Walter de Gruyter Berlin New York
Content. Course (LV 21246): Fr. 12:00-14:00 16 Lectures
Content Course (LV 21246): Fr. 12:00-14:00 16 Lectures Content 1: Overview Occurrence of carbohydrates in nature Glycopolymers and glycoconjugates Carbohydrates in animals Carbohydrates in bacteria and
Macrolides & Ketolides. Objectives. Protein Synthesis
Macrolides & Ketolides Elizabeth D. Hermsen, Pharm.D. Infectious Diseases Research Fellow University of Minnesota College of Pharmacy bjectives Participant should be able to explain macrolide/ketolide
From sugar unit A From sugar unit B From sugar unit C
ame 215 F12-Exam o. Page 2 I. (26 points) Raffinose is a trisaccharide occurring in cottonseed meal. Answer the following questions as directed in the boxes. (1) ( points) Label each of the glycosidic
Biosynthesis of Secondary Metabolites
Biosynthesis of Secondary Metabolites Secondary Metabolism Secondary metabolism, metabolic pathways that are not essential for growth, development or reproduction. Secondary metabolites are those chemical
Supporting Information
Supporting Information Wiley-VCH 2008 69451 Weinheim, Germany Chemoselective Peptide Cyclization via Induced Traceless Staudinger Ligation Rolf Kleineweischede, Christian P.R. Hackenberger* Institute for
Staurosporine. Saccharothrix aerocolonigenes subsp. staurosporeus AM-2282 T (Lentzea albida AM-2282) Chapter 1. Chapter 2. Chapter 3 H N O.
Chapter 1 Chapter 2 Staurosporine 1. Discovery, producing organism 23) Staurosporine was originally discovered in 1977 from culture of Saccharothrix aerocolonigenes starin AM-2282 T during a screening
STRUCTURE OF COMMONLY USED PENICILLINS
PENICILLINS Alice Prince I. CHEMISTRY A basic structure of penicillins consists of a nucleus with three components: a thiazolidine ring, a β-lactam ring and a side chain. The side chain determines, in
Antibacterials and Antivirals
Structure of a Bacterium: Antibacterials and Antivirals Capsule: protective layer made up of proteins, sugars and lipids Cell wall: provides the bacteria with its shape and structure Cell membrane: permeable
Chemistry of the Thyroid Gland: Thyroid Hormones and Antithyroid Drugs
Bioinorganic and Biomimetic Chemistry Chemistry of the Thyroid Gland: Thyroid ormones and Antithyroid Drugs G. Mugesh Department of norganic & Physical Chemistry ndian nstitute of cience Bangalore 560